InstalabLoading...
InstalabLoading...
If late summer and fall bring on sneezing, itchy eyes, wheezing, or strange reactions to celery, peaches, or spices, mugwort weed pollen may be the trigger. This test looks for IgE (immunoglobulin E), the antibody your immune system produces when it has learned to react to a specific allergen, in this case Artemisia (mugwort) pollen.
Knowing whether you make this antibody, and how strongly, helps explain seasonal symptoms, predict whether your respiratory allergy could become asthma, and flag a hidden risk of reactions to certain plant foods that share proteins with mugwort.
This is a blood test for IgE antibodies that specifically recognize proteins in mugwort pollen. IgE is made by B cells and plasma cells, immune cells that produce antibodies after a Th2-type immune response (the branch of immunity that drives allergy). When mugwort pollen lands on your airways, allergen-specific IgE binds to immune cells called mast cells and basophils. On the next exposure, those cells release histamine and other chemicals that produce allergy symptoms.
The standard test measures IgE against whole mugwort extract. More advanced "component-resolved" testing can break that down into individual mugwort proteins, including Art v 1 (a defensin-like protein that is the dominant marker of true mugwort sensitization), Art v 3 (a lipid transfer protein, or LTP, which is a small, stable plant protein that often drives food reactions), and Art an 7 (a 62-kilodalton protein linked to asthma risk).
Mugwort is a major late-summer and autumn weed pollen and is part of the standard European inhalant allergy panel. Sensitization to Artemisia is significantly associated with more severe intermittent rhinitis, the runny nose, congestion, sneezing, and itchy eyes that come and go with pollen seasons. Patients with higher mugwort IgE and IgE to multiple mugwort proteins tend to have more intense symptoms.
Mugwort allergy is one of the leading causes of asthma in northern China, and the pattern of sensitization matters. In a study of 240 patients with Artemisia pollen allergy, those sensitized to three or more mugwort components had a markedly higher risk of allergic asthma than those reacting to only one. A separate analysis in the Mu Us Desert region of China found that high environmental exposure to Artemisia desertorum pollen drives both asthma risk and pollen allergy prevalence, with molecular allergy diagnostics improving prediction of disease severity.
Mugwort can also be a trigger for severe acute attacks. In a Chinese epidemic of thunderstorm asthma in children, 94% of affected children had mugwort-specific IgE, suggesting that mugwort pollen fragments dispersed by storms can drive sudden, severe airway reactions in already-sensitized people.
Mugwort proteins look enough like proteins in some plant foods that the same IgE antibodies can attack both. This is called cross-reactivity, and it underlies the well-known mugwort-celery-spice syndrome, as well as reactions to peach, fruits, vegetables, legumes, mango, garlic, and sunflower seed.
In Chinese cohorts, roughly 30 to 70% of mugwort-allergic patients also have a mugwort-related food allergy. The Art v 3 lipid transfer protein component is a key biomarker for this and predicts food allergy, including food-induced anaphylaxis (a severe, whole-body allergic reaction), better than the basic mugwort extract test alone. In an Italian study of 7,176 patients, co-sensitization to Art v 1 and the ragweed protein Amb a 4 identified people at high risk of systemic food reactions.
A positive mugwort IgE means your immune system has produced antibodies to mugwort pollen. Higher numbers, and a higher number of recognized mugwort proteins, generally reflect a stronger allergic response and a higher likelihood of clinical symptoms. The total IgE to whole mugwort extract closely tracks the sum of IgE to its individual components (a strong correlation of about 0.92, where 1.0 would be a perfect match).
A low or undetectable result suggests little or no sensitization to mugwort itself, though it does not rule out other pollen, dust mite, or food allergies, which need their own tests.
There is no single, universally agreed cutpoint for mugwort IgE that defines clinical allergy, and assays differ between labs. The traditional positivity threshold of 0.35 kUA/L (kilounits of allergen-specific antibody per liter) was challenged in a study of 300 school-age children, where an optimal cut-off of 0.75 kUA/L performed better for several other inhalant allergens. Most labs still report mugwort IgE in classes from 0 to 6, where higher classes mean stronger sensitization.
The ranges below come from common ImmunoCAP-based reporting and are illustrative orientation, not a target. Your lab may use slightly different cutpoints or units, and a positive number alone does not mean you have clinical allergy without matching symptoms.
| Class / Tier | Range (kUA/L) | What It Suggests |
|---|---|---|
| Class 0 | Less than 0.35 | No detectable mugwort sensitization on standard reporting |
| Class 1 to 2 | 0.35 to 3.49 | Low to moderate sensitization, often subclinical or mild seasonal symptoms |
| Class 3 to 4 | 3.50 to 49.9 | Moderate to high sensitization, more likely to track with clinical symptoms |
| Class 5 to 6 | 50 or higher | Very high sensitization, often associated with multi-component reactivity and higher risk of asthma or food cross-reactions |
Compare your results within the same lab over time for the most meaningful trend, and pair the number with what your body actually does during pollen season.
A single mugwort IgE reading is a snapshot. Levels can rise during and after a heavy pollen season, drift downward in low-exposure years, and respond over time to allergen immunotherapy or sustained changes in exposure. A three-year retrospective study in northern China showed that house dust mite immunotherapy in polysensitized patients also reduced Artemisia-specific IgE, illustrating that these numbers move with treatment.
A practical approach: get a baseline before or just after pollen season, retest in 6 to 12 months if you start immunotherapy or change exposure significantly (move regions, work outdoors, etc.), and at least every 1 to 2 years if you have ongoing seasonal symptoms. Trends are more informative than any single value, especially because mugwort is one of the harder allergens for standardized assays, with weaker concordance between platforms than many other allergens.
A positive result is the start of a workup, not the end. The decision pathway depends on what symptoms you have and what else is on your panel.
Mugwort IgE is one of the more technically tricky allergen tests, and several factors can distort interpretation.
Patients and non-specialist clinicians sometimes assume that if a basic allergy panel looks fine, mugwort is not an issue. The evidence pushes back on that. Standard panels vary by region, and minimal panels in some parts of China use only five to six allergens. Combined with the lower sensitivity of mugwort assays, this means a clean limited panel does not reliably exclude mugwort sensitization. If your symptoms are seasonal, especially in late summer or fall, mugwort deserves to be tested specifically.
Evidence-backed interventions that affect your Mugwort Weed IgE level
Mugwort Weed IgE is best interpreted alongside these tests.